Huang Y - Search Results

1

Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer.

Zou J, Han Z, Zhou L, Cai C, Luo H, Huang Y, Liang Y, He H, Jiang F, Wang C, Zhong W. Zou J, et al. Among authors: huang y. Med Oncol. 2015 Jan;32(1):373. doi: 10.1007/s12032-014-0373-1. Epub 2014 Dec 3. Med Oncol. 2015. PMID: 25465060

2

Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer.

Huang YQ, Han ZD, Liang YX, Lin ZY, Ling XH, Fu X, Cai C, Bi XC, Dai QS, Chen JH, He HC, Chen YR, Jiang FN, Zhong WD. Huang YQ, et al. Med Oncol. 2014 Jan;31(1):820. doi: 10.1007/s12032-013-0820-4. Epub 2013 Dec 14. Med Oncol. 2014. PMID: 24338276

3

MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.

Lin ZY, Huang YQ, Zhang YQ, Han ZD, He HC, Ling XH, Fu X, Dai QS, Cai C, Chen JH, Liang YX, Jiang FN, Zhong WD, Wang F, Wu CL. Lin ZY, et al. Int J Cancer. 2014 Aug 1;135(3):541-50. doi: 10.1002/ijc.28707. Epub 2014 Jan 10. Int J Cancer. 2014. PMID: 24382668

4

Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer.

Qin GQ, He HC, Han ZD, Liang YX, Yang SB, Huang YQ, Zhou L, Fu H, Li JX, Jiang FN, Zhong WD. Qin GQ, et al. Onco Targets Ther. 2014 Jan 24;7:137-46. doi: 10.2147/OTT.S55432. eCollection 2014. Onco Targets Ther. 2014. PMID: 24493929 Free PMC article.

5

MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.

Fu H, He HC, Han ZD, Wan YP, Luo HW, Huang YQ, Cai C, Liang YX, Dai QS, Jiang FN, Zhong WD. Fu H, et al. Tumour Biol. 2015 Mar;36(3):1983-91. doi: 10.1007/s13277-014-2805-0. Epub 2014 Nov 15. Tumour Biol. 2015. PMID: 25394900

6

Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer.

Huang YQ, Sun T, Zhong WD, Wu CL. Huang YQ, et al. Am J Clin Exp Urol. 2014 Dec 25;2(4):343-50. eCollection 2014. Am J Clin Exp Urol. 2014. PMID: 25606581 Free PMC article. Review.

7

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.

Zeng YR, Han ZD, Wang C, Cai C, Huang YQ, Luo HW, Liu ZZ, Zhuo YJ, Dai QS, Zhao HB, Liang YX, Zhong WD. Zeng YR, et al. BMC Urol. 2015 Aug 29;15:90. doi: 10.1186/s12894-015-0085-7. BMC Urol. 2015. PMID: 26320076 Free PMC article.

8

miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.

Huang YQ, Ling XH, Yuan RQ, Chen ZY, Yang SB, Huang HX, Zhong WD, Qiu SP. Huang YQ, et al. Mol Med Rep. 2017 Sep;16(3):2431-2438. doi: 10.3892/mmr.2017.6910. Epub 2017 Jul 4. Mol Med Rep. 2017. PMID: 28677791 Free PMC article.

9

Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.

Huang Y, Huang H, Han Z, Li W, Mai Z, Yuan R. Huang Y, et al. Among authors: huang h. J Nanosci Nanotechnol. 2019 Apr 1;19(4):1942-1950. doi: 10.1166/jnn.2019.16404. J Nanosci Nanotechnol. 2019. PMID: 30486934

10

Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer.

Chen J, Huang Y, Tang Z, Li M, Ling X, Liao J, Zhou X, Fang S, Zhao H, Zhong W, Yuan X. Chen J, et al. Among authors: huang y. Front Cell Dev Biol. 2021 Jan 26;8:616332. doi: 10.3389/fcell.2020.616332. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33575255 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81,594 results

Search Page

Filters